Filing Details 60 DEGREES PHARMACEUTICALS, INC. (NASDAQ:SXTP) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 02, 2026. The…
60 DEGREES PHARMACEUTICALS, INC. (NASDAQ:SXTP) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 02, 2026.
The Healthcare company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
60 DEGREES PHARMACEUTICALS, INC.'s stock currently trades at $1.71 with a market capitalization of $2.8M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing 60 DEGREES PHARMACEUTICALS, INC.'s filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for 60 DEGREES PHARMACEUTICALS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SXTP Stock Page
Browse all filings on our SXTP SEC filings page.
Public companies like 60 DEGREES PHARMACEUTICALS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · SXTP
$1.01
Down: -$0.05 · -5.32%
Live quote updated
Keep reading
sec_filing ·
sec_filing ·
sec_filing ·
earnings ·
